BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 211 filers reported holding BLUEBIRD BIO INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $928,137 | -8.3% | 305,308 | -0.8% | 0.00% | – |
Q2 2023 | $1,012,514 | +108074.6% | 307,755 | +4.6% | 0.00% | – |
Q1 2023 | $936 | -87.5% | 294,209 | -72.9% | 0.00% | -100.0% |
Q4 2022 | $7,504 | -99.9% | 1,084,350 | -3.2% | 0.00% | 0.0% |
Q3 2022 | $7,090,000 | +427.1% | 1,120,044 | +244.6% | 0.00% | +200.0% |
Q2 2022 | $1,345,000 | -40.2% | 325,049 | -30.4% | 0.00% | 0.0% |
Q1 2022 | $2,248,000 | -50.2% | 467,276 | +3.4% | 0.00% | 0.0% |
Q4 2021 | $4,515,000 | -57.4% | 451,977 | -18.6% | 0.00% | -66.7% |
Q3 2021 | $10,606,000 | -52.0% | 554,981 | -19.6% | 0.00% | -57.1% |
Q2 2021 | $22,082,000 | +53.1% | 690,476 | +44.4% | 0.01% | +40.0% |
Q1 2021 | $14,419,000 | -43.3% | 478,226 | -18.7% | 0.01% | -44.4% |
Q4 2020 | $25,439,000 | -24.1% | 587,928 | -5.4% | 0.01% | -30.8% |
Q3 2020 | $33,519,000 | -24.5% | 621,299 | -14.5% | 0.01% | -27.8% |
Q2 2020 | $44,368,000 | +86.1% | 726,869 | +40.1% | 0.02% | +50.0% |
Q1 2020 | $23,842,000 | -45.7% | 518,745 | +3.7% | 0.01% | -29.4% |
Q4 2019 | $43,909,000 | +16.3% | 500,390 | +21.7% | 0.02% | +13.3% |
Q3 2019 | $37,753,000 | -28.9% | 411,165 | -1.5% | 0.02% | -28.6% |
Q2 2019 | $53,104,000 | +8591.3% | 417,480 | +12075.0% | 0.02% | +425.0% |
Q4 2017 | $611,000 | +28.9% | 3,429 | -0.7% | 0.00% | +33.3% |
Q3 2017 | $474,000 | +30.6% | 3,454 | -0.0% | 0.00% | +50.0% |
Q2 2017 | $363,000 | -73.8% | 3,455 | -77.3% | 0.00% | -75.0% |
Q1 2017 | $1,386,000 | -11.4% | 15,249 | -39.9% | 0.01% | 0.0% |
Q4 2016 | $1,565,000 | -11.4% | 25,359 | -2.7% | 0.01% | -20.0% |
Q3 2016 | $1,767,000 | -81.3% | 26,069 | -76.4% | 0.01% | -81.5% |
Q3 2015 | $9,459,000 | -43.8% | 110,564 | +10.6% | 0.05% | -40.0% |
Q2 2015 | $16,838,000 | +18.5% | 100,007 | -15.0% | 0.09% | +15.4% |
Q1 2015 | $14,211,000 | +21.7% | 117,668 | -7.6% | 0.08% | +18.2% |
Q4 2014 | $11,681,000 | – | 127,359 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
Summit X, LLC | 103,424 | $651,000 | 0.19% |